Clinical Trial Update: TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TQB2618 in combination with Penpulimab for recurrent/metastatic nasopharyngeal carcinoma has completed. Sponsor: Chia Tai Tianqing Phar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Penpulimab
• TQB2618

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED